Aravive Announces Executive Management Transition Plan

NEXT STORY
Checkpoint Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
PREV STORY
Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Avian Influenza (Infectious Disease) Drugs Development Market Report 2021: Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type

author_avatar
NASDAQ Market News

Argos Therapeutics to Hold Conference Call to Discuss Update on the Phase 3 ADAPT Trial Presented at the ESMO 2017 Congress

DURHAM, N.C., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News

Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics

author_avatar
NASDAQ Market News